Madhav Thambisetty

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Longitudinal changes in cortical thickness associated with normal aging
    Madhav Thambisetty
    Laboratory of Personality and Cognition, National Institute on Aging, Baltimore, MD 21224 2816, USA
    Neuroimage 52:1215-23. 2010
  2. ncbi Blood-based biomarkers of Alzheimer's disease: challenging but feasible
    Madhav Thambisetty
    Laboratory of Personality and Cognition, Intramural Research Program, National Institue on Aging, NIH, USA
    Biomark Med 4:65-79. 2010
  3. ncbi APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging
    Madhav Thambisetty
    Department of Radiology and Radiological Sciences, Laboratory of Personality and Cognition, National Institute on Aging, National Institutes of Health, Johns Hopkins University, Baltimore, Maryland 21224 6825, USA
    Arch Neurol 67:93-8. 2010
  4. ncbi Baseline cardiovascular risk predicts subsequent changes in resting brain function
    Lori L Beason-Held
    Intramural Research Program, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
    Stroke 43:1542-7. 2012
  5. ncbi Proteome-based plasma markers of brain amyloid-β deposition in non-demented older individuals
    Madhav Thambisetty
    National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA
    J Alzheimers Dis 22:1099-109. 2010
  6. ncbi Plasma biomarkers of brain atrophy in Alzheimer's disease
    Madhav Thambisetty
    Laboratory of Behavioral Neuroscience, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, United States of America
    PLoS ONE 6:e28527. 2011
  7. ncbi Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment
    Madhav Thambisetty
    Laboratory of Behavioral Neuroscience, National Institute on Aging, Baltimore, MD 21224, USA
    Neuroimage 59:212-7. 2012
  8. ncbi The utility of (11)C-arachidonate PET to study in vivo dopaminergic neurotransmission in humans
    Madhav Thambisetty
    Brain Physiology and Metabolism Section, National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Cereb Blood Flow Metab 32:676-84. 2012

Detail Information

Publications8

  1. ncbi Longitudinal changes in cortical thickness associated with normal aging
    Madhav Thambisetty
    Laboratory of Personality and Cognition, National Institute on Aging, Baltimore, MD 21224 2816, USA
    Neuroimage 52:1215-23. 2010
    ..Significant nonlinear changes over time were observed in the postcentral, precentral, and orbitofrontal gyri on the left and inferior parietal, cingulate, and orbitofrontal gyri on the right...
  2. ncbi Blood-based biomarkers of Alzheimer's disease: challenging but feasible
    Madhav Thambisetty
    Laboratory of Personality and Cognition, Intramural Research Program, National Institue on Aging, NIH, USA
    Biomark Med 4:65-79. 2010
    ....
  3. ncbi APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging
    Madhav Thambisetty
    Department of Radiology and Radiological Sciences, Laboratory of Personality and Cognition, National Institute on Aging, National Institutes of Health, Johns Hopkins University, Baltimore, Maryland 21224 6825, USA
    Arch Neurol 67:93-8. 2010
    ..Design, Setting, and..
  4. ncbi Baseline cardiovascular risk predicts subsequent changes in resting brain function
    Lori L Beason-Held
    Intramural Research Program, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
    Stroke 43:1542-7. 2012
    ....
  5. ncbi Proteome-based plasma markers of brain amyloid-β deposition in non-demented older individuals
    Madhav Thambisetty
    National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA
    J Alzheimers Dis 22:1099-109. 2010
    ..Our strategy combining proteomics with in vivo brain amyloid imaging holds promise for the discovery of biologically relevant peripheral markers in those at risk for AD...
  6. ncbi Plasma biomarkers of brain atrophy in Alzheimer's disease
    Madhav Thambisetty
    Laboratory of Behavioral Neuroscience, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, United States of America
    PLoS ONE 6:e28527. 2011
    ..Moreover, these proteins are involved in complement activation and coagulation, providing further evidence for an intrinsic role of these pathways in AD pathogenesis...
  7. ncbi Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment
    Madhav Thambisetty
    Laboratory of Behavioral Neuroscience, National Institute on Aging, Baltimore, MD 21224, USA
    Neuroimage 59:212-7. 2012
    ..These findings in combination suggest an influence of this multi-functional protein on early stages of progression in AD pathology...
  8. ncbi The utility of (11)C-arachidonate PET to study in vivo dopaminergic neurotransmission in humans
    Madhav Thambisetty
    Brain Physiology and Metabolism Section, National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Cereb Blood Flow Metab 32:676-84. 2012
    ..1-(11)C]AA PET may be useful for studying disturbances of dopaminergic neurotransmission in conditions such as Parkinson's disease and schizophrenia...